Insta
Bharat Biotech Completes Phase 2/3 Trials Of Covaxin In Children Aged Below 18 Years
Swarajya Staff
Sep 22, 2021, 01:35 PM | Updated 01:35 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Bharat Biotech has completed the phase 2/3 trials of Covaxin for vaccination of children aged under 18.
The company will be submitting its data to the Drug Controller General of India (DCGI) in the coming week.
Bharat Biotech MD Krishna Ella confirmed about the data analysis regarding the trials is ongoing and will be filed in soon.
“Paediatric Covaxin just completed phase 2/3 trials. The data analysis is going on. We will be submitting the data (to the regulator) by next week. The number of subjects (volunteers) is touching 1,000,” he was quoted by the Press Trust of India (PTI).
Moreover, the second phase trials of the company’s intranasal Covid-19 vaccine will too conclude towards the end of September. Apparently, the intranasal vaccine evokes an immune response in the nose, which is considered to be entry point for the virus in the human body.
This vaccine is undergoing trials on about 650 volunteers who have been segregated into three different groups for the procedure.
Ella also put light to the fact that the production of Covaxin is increasing in Bengaluru and hence the company will be supplying 55 million doses of the vaccine in October as compared to 35 million delivered in September.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.